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 1 INTRODUCTION 
The compound similar to cholesterol was first mentioned as early as two hundred forty 
years ago (Poulletier de la Salle 1769), but present term “cholesterol” should be inscribed to 
another French, M.E. Chevreul (1815)1. Since that time, thousands of steroids, compounds 
with steran tetracyclic system, have been isolated in living organisms. The vast structural 
diversity of steroids is reflected in broad spectrum of their effects. The subtle part of steroids, 
sterols, is characterized with the hydroxyl group on the third carbon atom of the steroid core. 
This group is mainly represented by cholesterol and its precursors as well as by plant sterols 
(phytosterols). The intermediates of cholesterol biosynthesis and phytosterols could be named 
together as noncholesterol sterols. Until recently, it was assumed that cholesterol precursors 
do not possess any clinically important features and that the variety of precursors is simply 
due to complicated final structure of cholesterol. Nowadays, some of these intermediates are 
supposed to play a role. Together with the obvious fact that the concentration of intermediates 
reflects the level of biosynthesis of cholesterol, we have another impetus for the analyses of 
these compounds. 
Fatty acids are another large group of lipids with no less voluminous variety of effects. 
They are present in biological membranes and function as ligands of nuclear factors, signal 
molecules and precursors of several types of compounds, with eicosanoids on one end and 
miscellaneous functional derivatives on the other. The essentiality of fatty acids with two and 
more double bonds adds another nutritional aspect into the rich mosaic of effects of fatty acids 
on our organism. This group of fatty acids is life important and therefore, it should deserve 
more attention even of lay public. 
The structural motif of sterol and fatty acid chain cross-talk on several levels of 
metabolism. The cholesterol and fatty acid molecules interact in cell membranes and they are 
responsible for physical properties of biological membranes. Cholesterol and fatty acid form 
the molecule of cholesteryl ester, the storage form of cholesterol in the intracellular space and 
inner part of lipoprotein particles in extracellular compartment (mainly plasma).  Furthermore, 
sterol as well as fatty acid structures are important structural motifs of ligands, which take 
part in transcriptional mechanisms governing many of the genes of the lipid homeostasis. The 
target genes are in several cases regulated by both cholesterol and fatty acids. 
The cohesion of the metabolism of cholesterol and fatty acids, which reaches from 
physical interaction in the membrane as far as to the competition as ligands for gene 
transcription, raises the question whether there is connection in the metabolism of cholesterol 
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 and fatty acids, especially in the case of pathophysiological events with disturbed lipid 
metabolism (cholesterol homeostasis and transformation of fatty acids). 
 
2 AIM OF THE THESIS 
The aims of the Thesis were as follows:  
 
1. To modify the methodological approach for the determination of noncholesterol sterols 
and fatty acids in human plasma by the capillary gas chromatography. 
 
2. With the respect of data obtained by the analysis of noncholesterol sterols and fatty 
acids as well as other biochemical analyses, to suggest (in chosen diseases) possible 
pathological mechanisms derived from the relationship of metabolism of cholesterol and fatty 
acids. 
 
3 METHODS AND PATIENTS 
Analytical Methods 
The analyses of the fatty acid profile in lipid classes of plasma (cholesteryl esters, 
triacylglycerols and phospholipids, phosphatidylcholines, resp.) and triacylglycerols of 
adipose tissue were carried by capillary gas chromatography. The concentrations of plasma 
noncholesterol sterols were also analysed by the same method. The supplemental biochemical 
analyses were performed with standard methods in lipid or central laboratory of General 
teaching hospital; if the separation of LDL was necessary, the sequential ultracentrifugation 
step2 was introduced into the sample handling scheme. The extraction of lipids from brain 
tissue followed the procedure by Folch3 and the separate lipid classes in the extract were 
quantitatively analysed by thin-layer chromatography with flame-ionisation detection4.  
 
Experimental Model 
Male Wistar rat were chosen for the experimental study; prior to the study launch, they were 
grouped according to the plasma triacylglycerol and cholesterol levels so the groups did not 
differ from each other. The rats were caged by four in standardized conditions and they were 
administered with hypolipidemic drugs or placebo. 
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 Patients 
The groups of patients under investigation included persons with anorexia nervosa, proteino-
energetic malnutrition, the obese, hyperlipidemic patients as well as the control group. The 
anthropometrical and clinical characteristics of all the persons were acquired by medical 
examination. The control group included the employees of the IVth Department of Medicine, 
1 LF UK, and their relatives, or person enrolled on another voluntary basis. For the inclusion 
or exclusion of the person into the relevant group, we applied appropriate criteria 5,6,7. All the 
participants were informed about the study and signed informed consent with the study. All 
studies were approved by ethical committees.  
 
Statistical Evaluation of the Data  
Data from the studies were statistically processed with commercial software STATISTICA® 
for Windows; during the procedure, both parametrical and nonparametric one-dimensional 
approach was used. Multidimensional analysis of the data was used for multiple distribution 
comparison with Hotteling t-test. Correlation analysis took the advantage of the same program 
with the exception of comparison of regression lines; in this case, the program in the 
Microsoft Excel® for Windows environment was configured on the basis of linear regression 
theory8. 
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 4 PRINCIPAL RESULTS OF THE THESIS 
4.1 Methodological Studies 
Effect of Column and Software on Gas Chromatographic Determination of Fatty 
Acids – Study I 
Four capillary columns (A: CP-WAX 52 CB 25 m x 0.25 mm; B: CP WAX 52 CB 30 m 
x 0.25 mm; C: CP-WAX 58 CB 25 m x 0.25 mm, Chrompack; D: OMEGAWAX™ 320 30 m 
x 0.32 mm, Supelco) and two integration software (Mosaic® v.5.10, Chrompack and CSW 
v.1.7, Data Apex®) were compared for analysis of fatty acids. Column A was mounted 
stepwise in two different instruments. Fatty acids of blood plasma phosphatidylcholine and 
standard mixture of saturated fatty acids were analysed as methyl esters under identical 
chromatographic conditions. Both integrating software did not differ significantly in most 
results; differences were observed only for minor components: 16:1n-9, 20:0 and 20:2n-6. 
Increased values for 16:1n-9 and 20:2n-6 integrated by MOSAIC are caused by cointegration 
of two poorly resolved peaks: fatty acid and impurity from sample matrix. Lower values for 
20:0 are caused by incomplete integration of minor peak. Differences between columns were 
observed mostly for minor fatty acids. Linear calibration dependences measured with standard 
mixture of saturated fatty acids (carbon number 10–24) were observed in wide range of 
concentrations (three orders). Slope close to unity and minimal value of intercept confirmed 
theoretical relations when analyses are run under optimal conditions.  
 
Effect of analytical matrix on fatty acid analysis – Study II 
Profiles of fatty acids in lipid classes of plasma and ultracentrifugally separated 
lipoproteins were analyzed by capillary gas chromatography. Contribution of individual steps 
of the whole procedure was calculated on the basis of the multiple analyses. GC contributes to 
the overall error by the smallest part. Contribution of the extraction, thin-layer 
chromatography separation and methylation processes might be comparable. The value of 
relative standard deviation is indirectly proportional to the amount of analyzed component. 
Comparison of FA profiles in lipid classes of very low density lipoproteins and low density 
lipoproteins revealed highly individual differences. Increased content of arachidonic and 
docosahexaenoic acids in triglycerides of low density lipoproteins are in agreement with 
formerly published results.  
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 Comparison of Fatty Acid Profile in Serum Phospholipids and 
Phosphatidylcholines – Study III 
The aim if this study was to statistically evaluate the effect of individual steps of the 
fatty acid analysis (thin-layer chromatography, transmethylation reaction and gas 
chromatography) in the isolated phosphatidylcholines and the fatty acid profile compare with 
that of phospholipids. 
Both types of analyses revealed significant differences for most fatty acids. High level 
of significances for the differences between fatty acid profile in phosphatidylcholines and 
phospholipids were due to repeated analyses with little total error of the method. However, 
these differences were negligible compared to deviation within the biological samples and 
they did not exhibit systematic bias for the samples analysed. 
 
Analyses of Noncholesterol Sterols – Study IV 
Usually, clinical practice requires the analysis of the sum of free and esterified sterol 
molecules from the unsaponifiable part of the serum/plasma. The optimization of the 
analytical method was focused on some steps of the analytical process. 
Acetylation was preferred to analysis of free sterol due to better analytical conditions. 
The acetylation procedure gave the highest reproducibility (RSD 2 %) and almost the highest 
yield at room temperature for 24 hours in the dark. Heating of the samples is not 
recommended. Injection mode for further analyses was set to split because it gave higher 
slopes in calibration dependencies; moreover, in some clinical samples, in the splitless mode 
some “ghost” peaks appeared. For the injector configuration in use, we did not prove the 
different effect of injection with 7 cm and 5 cm needle.  
The response factors for different injection volumes in case of 5α-cholestanol, 
lathosterol and β-sitosterol are comparable. With the injection volumes reaching minimal 
values, the more pronounced effect of matrix giving poorer reproducibility should be 
expected. The possibility of analysis of both cholesterol and noncholesterol sterols in one 
chromatographic run was studied. It was not possible to obtain reproducible results for one 
run analysis, therefore this limitation was overcome with two dilution and two internal 
standard method, i.e. two chromatographic analyses are necessary. 
Furthermore, the contribution of separate steps of the plasma noncholesterol analysis 
was determined. The quantitative assessment of lanosterol and 5α-cholestanol is biased with 
error excluding the use of this analytical method for clinical samples. 
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 4.2 Experimental Study 
Hypolipidemic Drugs Can Change the Composition of Rat Brain Lipids – Study V 
Hypolipidemic drugs are potent serum cholesterol lowering agents used for prevention 
of coronary heart disease. In addition to their cholesterol lowering effect, the hypolipidemic 
drugs exhibit both pleiotropic beneficial and various neurological side effects. Therefore, we 
analysed effect of these drugs (three statins, reversible competitive inhibitors of cholesterol 
biosynthesis and fenofibrate, the drug affecting primarily plasma high triacylglycerol with 
indirect effect on plasma cholesterol) on membrane lipid composition in the rat brain tissue. 
Male Wistar rats were given 0.1 mg of fenofibrate, lovastatin, pravastatin, fluvastatin or 
placebo once daily for six weeks. In lovastatin and pravastatin treated groups, decreased 
cholesterol and increased ceramide monohexoside contents in the brain tissue were observed 
in comparison with control group. Fluvastatin and lovastatin treatment resulted in increased 
sphingomyelin and decreased diphosphatidylglycerol contents. The most important changes in 
fatty acid profile were observed in ceramide monohexosides: in fluvastatin group, decreased 
content of saturated and increased content of polyunsaturated fatty acids. Fenofibrate dosage 
led to decreased content of saturated fatty acids in phosphatidylethanolamines.  
 
4.3 Clinical Studies 
Composition of Plasma Fatty Acids and Non-Cholesterol Sterols in Anorexia 
Nervosa – Study VI 
Anorexia nervosa is a model of simple starvation accompanied by secondary 
hyperlipoproteinemia. Pattern of plasma fatty acid influences levels of plasma lipids and 
lipoproteins. Concentration of plasma lathosterol is surrogate marker of cholesterol synthesis 
de novo, concentrations of campesterol and β-sitosterol reflect resorption of exogenous 
cholesterol. The aim of the study was to evaluate fatty acids in plasma lipid classes and their 
relationships to plasma lipids, lipoproteins, cholesterol precursors and plant sterols.  
We examined 16 women with anorexia nervosa and 25 healthy ones. Patients with 
anorexia nervosa revealed increased concentrations of total cholesterol, triglycerides, HDL-
cholesterol, campesterol and β-sitosterol. Moreover, decreased content of n-6 polyunsaturated 
fatty acids in all lipid classes was found. These changes were compensated by the increased 
content of monounsaturated fatty acids in cholesteryl esters, saturated fatty acids in 
triglycerides and both monounsaturated and saturated fatty acids in phosphatidylcholine. The 
most consistent findings in fatty acid pattern were decreased content of linoleic acid (LA, 
18:2n-6) and raised content of palmitoleic acid (POA, 16:1n-7) in all lipid classes.  
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 Plasma Fatty Acids and Sterols in Protein-energetic Malnutrition – Study VII 
Proteino-energetic malnutrition, as a result of different types of starvation, represents 
serious complication for patients in critical care. The aim of our study was to find changes in 
lipid and lipoprotein parameters in proteino-energetic malnutrition, which usually are not 
included in standard profile of analyses. Group of patients with PEM consisted of 22 persons 
(12 M/10 F), the control one of 35 healthy persons (10 M/25 F).  
Patients with proteino-energetic malnutrition had lower concentrations of total 
cholesterol both in plasma and lipoprotein particles as well as apoA-I compared with controls. 
The lathosterol concentration was not changed, but lathosterol/total cholesterol ratio was 
significantly higher than that of controls and one of the indices of cholesterol absorption, 
campesterol/total cholesterol ratio, was lowered. One-dimensional statistical analysis revealed 
lowered contents of myristic (14:0), linoleic (18:2n6) and α-linolenic (18:3n-3) acid, whereas 
the content of oleic acid (18:1n-9) was higher in all lipid classes. In the all lipid classes, these 
changes were pronounced as higher content of monoenoic fatty acids and lower content of 
polyunsaturated fatty acids in both n-6 and n-3 series. 
 
Fat Content in Low-energy Diet Fatty Acids and Metabolism of Cholesterol – 
Study VIII 
Recently, a new attention has been paid to beneficial effects of high-fat diet on body 
weight reduction and metabolic profile in obese subjects. Reduction diets often cause low 
cholesterol levels, which can be caused by decrease in dietary cholesterol absorption and/or 
low cholesterol biosynthesis. The homeostasis of cholesterol under the condition of reduction 
diet is influenced also by the presence of noncholesterol sterols and fatty acids in the fat 
portion of the diet. In this study, we compared the effects of two hypocaloric diets with 
different proportion of fat on the homeostasis of cholesterol and fatty acid composition in 
blood and adipose tissue. 
Forty-four obese subjects were submitted to 10 weeks´ low-calorie diet. Subjects were 
randomized into low-fat diet (LFD) (20-25 % of energy content) and high-fat diet groups 
(HFD) (40-45 %). Before and at the end of the intervention, samples of blood and 
subcutaneous adipose tissue were taken for subsequent analysis of fatty acid composition, 
plasma biochemistry parameters and noncholesterol sterols.  
The diet-induced body weight and fat mass reduction were not different between the two 
diets. Plasma triacylglycerols were reduced during HFD only. Both diets reduced proportion 
of n-3 polyunsaturated fatty acids in adipose tissue and of saturated fatty acid in blood 
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 triacylglycerols, with no difference between the diets. HFD induced a higher increase of 
monounsaturated fatty acids in blood triacylglycerols. No other diet-induced changes were 
found in proportion of major classes of fatty acids. In respect to individual fatty acids, the 
diets induced a number of changes in adipose tissue and blood, the changes, however, not 
being different between the diets. The HFD and LFD groups had lower cholesterol levels that 
were caused in HFD group by lower content of cholesterol in VLDL, whereas LFD group 
exhibited lower LDL cholesterol. We did not observe any changes in plasma lathosterol in 
both groups, but we detected in both groups lower concentrations of phytosterols campesterol 
and β-sitosterol. 
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 5 DISCUSSION  
Methodological studies 
The analysis of fatty acid profile in plasma is necessary part of dietary studies9. The 
growing interest in some groups of fatty acids imposes high demand on their analysis, which 
has to be based on validated procedures in case of obtaining absolute data10. For example, 
PUFA n-3 are dietary supplements with proven hypocholesterolemic effect. The analysis of 
fatty acids by gas chromatography is nowadays a highly sophisticated procedure with vast 
number of detailed applications11. The favourite approach is the split/splitless injection mode 
of isolated mixture of fatty acid methyl esters into capillary columns that are in present 
produced in wide range of length as well as of polarity of the stationary phases so that the 
analysis could be easily set according to the requirements of the analysed profile of fatty 
acids. If the injection mode is set as a split/splitless one, the effect of injection parameters, 
like the split flow, the temperature of the split chamber and the injector configuration are of 
minor importance for fatty acid methyl ester analysis12. Therefore, our methodological studies 
focused on the effect of other steps of the analysis in lipid classes of human plasma. 
In study I, we drew our attention to the column and integration software used. The 
identification of minor components in complicated chromatographic record need reliable 
configuration of the method and well-equipped integrating software. The difference between 
the content of major fatty acids and the fatty acids around the detection limit reaches three 
orders of magnitude. Even though, these minor fatty acids undoubtedly have clinical 
significance, e.g. conjugated linoleic acid, trans isomers of fatty acids, and Mead’s acid 
(20:3n-9)9,13. The integration of minor peaks requires manual corrections; the modern 
software equipment with user-friendly interface allows for easy practice of these corrections. 
This is absolutely necessary for the separation of the peaks, for which it is not possible to set 
simple decision process suitable for the automatic handling of the data (e.g. unidentified 
component between 16:1n-9 and palmitoleic acid). In such a case, the imprecision would 
considerably influence the assessment of these two fatty acids. Moreover, palmitoleic acid is 
used a marker of lipogenesis14. 
In some studies, it is possible to decide which analytical matrix can be used. In study II, 
we focused on two analytical matrices (whole plasma and lipoprotein particles). The 
metabolism of fatty acid in plasma compartment is very complex and in tight relation to the 
metabolism of lipoproteins15. Furthermore, the release of fatty acids from adipose tissue and 
their binding to albumin play a role. The differences between the content of individual fatty 
acids in separate lipoprotein particles are negligible16. The little difference is probably caused 
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 by wide exchange processes that include all lipid classes and involve all the lipoproteins. The 
variation of fatty acid content of LDL and whole plasma (study II) did not reach the values of 
the deviation of clinical set, for the LDL particles transfer most plasma cholesteryl esters and 
phospholipids17. Plasma triacylglycerols are transported predominately in VLDL and LDL 
particles. The comparison of fatty acid content in triacylglycerols in VLDL and LDL (study 
II) revealed considerable differences that even exceeded the total error of the analysis in case 
of PUFA. 
Interestingly, clinical studies sometimes do not distinguish between the phospholipids and 
phosphatidylcholines. Phosphatidylcholines make for the most of phospholipids in human 
plasma and this is usually not further expanded on, it is only supposed that the content of fatty 
acid would be the same. This presumption was put into question in study III, and it was 
shown to be true. Yet, in some study design the carefulness is recommended – the observation 
of the metabolism of individual fatty acids in the lipid classes of plasma or the issue of 
positional isomers in lipid classes. 
The analysis of minor plasma sterols is nowadays only a matter of marginal concern. The 
precursors of cholesterols are determined (above all) for the diagnosis on inborn errors of 
cholesterol biosynthesis and cerebrotendinous xanthomatosis, the analysis of phytosterols is 
indicated in suspected sitosterolemia18. Recently, the attempts for evaluation of liver 
function19 and prediction of hypocholesterolemic treatment20 based on the analysis of 
noncholesterol sterols appeared. Phytosterols and their saturated analogues, phytostanols, are 
suitable dietary supplements for cholesterol reduction with concomitant lowering of 
absorption of lipophilic vitamins. The maximum hypocholesterolemic effect of phytosterols 
(phytostanols) is reached in the daily dose around 2 g, higher intake has no additive effect and 
it is not recommended21. The monitoring of these sterols would be of clinical importance. 
Methodological part of the analysis of noncholesterol sterols is described in study IV. This 
study dealt with the effect of the type on injection technique and consequent derivatization on 
the calibration dependencies. The split injection mode brings about some disadvantage, but 
this was partly eliminated with the acetylation of the samples. It is also shown that the 
simultaneous determination of cholesterol and minor sterols in one chromatographic run is not 
possible; the contribution of individual steps of the analysis to the total error is studied in 
study IV, too. On the contrary to the determination of fatty acids, the gas chromatography 
burdens the total error substantially. Nevertheless, considering this error in comparison with 
the variance of the clinical set, the configuration of the method for the analysis of 
noncholesterol sterols is still recommendable. 
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Experimental study 
Some authors associate the metabolism of cholesterol with the function of nervous 
system22; low cholesterol concentration was linked with the changes in mood and anxiety 
disorders23. Even though undesirable side effects of the hypolipidemic drugs (with annual 
turn-over about 20 billion dollars, ref. 24) are closely watched, the drugs with cholesterol 
lowering effects could have some unpredictable effect on the central nervous system, which 
can be triggered  outside the brain. Fenofibrate, the drug that does not primarily affect the 
cholesterol metabolism, had no effect on the concentration of the brain lipids. The molecule 
of (phyto)sterol is probably transferred through the blood brain barrier, because in 
phytosterolemic patients (suffering from accumulation of phytosterols), phytosterols had been 
accumulated also in the brain25. The changes of cholesterol content in the membranes of 
neuronal tissue were in study V connected with the changes in the sphingolipid content, which 
could reflect the effort of the cell to maintain the membrane fluidity, the important factor for 
the proper function of the membrane. 
On the contrary to (chole)sterol molecules, the transfer of essential fatty acids (mainly 
docosahexaenoic and arachidonic) through the blood-brain barrier is obvious, because these 
fatty acids are absolutely necessary for the proper function as well as the development of the 
brain26 and mammals are not able to synthesise them in situ. In Study V, both statins used and 
fenofibrate were proven to have an effect on the content of fatty acids in brain lipids. For 
example, in brain phosphatidylethanolamines, the content of stearic acid was lowered and the 
content of docosahexaenoic acid was higher after the administration of fenofibrate. The link 
between the metabolism of fatty acids in plasma and brain is probably more complicated than 
that of cholesterol, since both fenofibrate and the statins used influenced the content of several 
fatty acids in brain lipid classes only to some extent. 
 
Clinical studies 
The homeostasis of cholesterol is governed by several processes, which include the 
absorption in the gut, the biosynthesis (in liver and adipose tissue), and the conversion of 
cholesterol to bile acids; the last pathway represents the main route of elimination of the 
cholesterol from the organism. The adjustment of regulation processes and their sensitivity is 
also the result of cholesterol content in liver27. In our studies (Study VI, VII, VIII), we 
focused on the quantitative assessment of absorptional and biosynthetic processes. This 
evaluation can be accomplished by the determination of serum/plasma noncholesterol sterols. 
11 
 Usually, there is a negative correlation between the markers of absorption (phytosterols) and 
cholesterol biosynthesis (the precursors)28. If the correlation is not observed, another factor 
plays a role, e.g. the release of (phyto)sterols from the adipose tissue during the dietary 
intervention (Study VIII); consequently, the cholesterol homeostasis is not established. The 
effect of several factors on the relationship between absorption and biosynthesis of cholesterol 
is indicated on the Figure 1.  
 
Figure 1 Factors influencing the cholesterol homeostasis 
 
CH – cholesterol, AN – anorexia nervosa, PEM – protein-energetic malnutrition 
 
The changes in the metabolism of cholesterol and fatty acids in anorexia nervosa lead to 
(in some cases) hypercholesterolemia29 with the PUFA n-6 deficiency30. Although in these 
cases the equilibrium between the cholesterol biosynthesis and absorption can be established, 
the high cholesterol levels are probably caused by the adjustment of the resorption process 
onto elevated level (Study VI). The patients had no changes in markers of cholesterol 
biosynthesis; anorectic states with the body weight far below the ideal value are supposed to 
use energy for absorption rather than for the cholesterol biosynthesis that require more 
energy. The high concentration of triacylglycerols in serum together with the observed 
hypercholesterolemia indicates that these patients have reduced catabolism of lipoproteins 
(Study VI).  
The group of patients with protein-energetic malnutrition had lower BMI (Study VII) 
concomitant with enhanced level of cholesterol biosynthesis and diminished level of 
12 
 exogenous cholesterol absorption. In plasma, the concentration of total cholesterol was 
probably decreased due to low HDL and LDL cholesterol. Cholesterol is intensively utilised 
for the cell membrane repair, the reverse cholesterol transport is limited together with the 
remodelation of HDL particles. The lower ratio of apoA-I/HDL-C (0.92 ± 0.31 vs. 1.34 ± 0.28 
in control group; p < 0.0001 with Mann-Whitney test) indicates the replacement of apo A-I 
probably by serum amyloid protein A during the inflammatory response31.  
The opposite nutritional state, the obese (Study VIII), had in comparison with the 
control group higher value of lathosterol/total cholesterol ratio (1.50 ± 0.40 vs. 1.06 ± 0.05 in 
control group; p < 0.01 by Mann-Whitney test) and lower value of campesterol/total 
cholesterol ratio (1.68 ± 0.62 vs. 3.38 ± 0.31 in control group; p < 0.001 by Mann-Whitney 
test). High body weight is usually connected with increased biosynthesis of cholesterol both 
in non-diabetic32 and diabetic with insulin independent type diabetes mellitus33. Insulin 
dependent diabetes is predominantly linked with higher absorption and low biosynthesis of 
cholesterol33; the anabolic effect of insulin probably plays a role. The factors influencing the 
adjustment of cholesterol homeostasis have also genetic background in case of absorption34, 
but not in case of cholesterol biosynthesis28. The dietary intake of cholesterol and saturated 
fatty acids influences (with respect to the proportion of cholesterol absorption) the 
homeostasis of cholesterol35. When the body weight is slightly lowered without change in 
plasma insulin concentration, there is any change in cholesterol biosynthesis, whereas the 
metabolism of phytosterols is modified either in the sense of lowered absorption and/or 
deteriorated mobilisation of phytosterols from adipose tissue (Study VIII). With the respect to 
the fact that the obese prevailingly belong to the hypoabsorbers of (chole)sterol and the 
dietary intake of cholesterol as well as  saturated fatty acids was not changed, the decreased 
concentration of phytosterols could be ascribed to the processes taking place in the adipose 
tissue (phytosterol accumulation in adipocytes or worsened mobilization of sterol molecules 
from adipocytes).  
Malnutrition states and obesity bring about complex changes in fatty acid content of all 
lipid classes. The content of fatty acid is the product of many factors, which could be 
quantitatively assessed only with the highest diligence and many methodological difficulties. 
In clinical studies, it is possible to estimate some factors indirectly. From the results presented 
in Study II, it could be inferred that the fatty acid content in whole plasma compartment and 
LDL is roughly the same. Desaturation, elongation and β-oxidation processes could be 
estimated from the product/substrate ratios in relevant metabolic pathways (e.g. Study VI), the 
level of peroxidation of fatty acids by the determination of e.g. kinetics of conjugated dienes 
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 in LDL or the total antioxidant status or the analysis of lipid peroxides. The process of the 
release of fatty acids from the adipose tissue is approximately proportional to the 
concentration of non-esterified fatty acid in plasma; the dietary intake of fatty acid could be 
evaluated by dietary records related to high-quality databases (e.g. Study VIII).  
The relationship of fatty acid and cholesterol in plasma is projected to several levels of 
metabolism - directly into the formation of cholesteryl esters, indirectly by the formation as 
well as remodelling of lipoprotein particles, the influence on gene expression and interactions 
in cell membranes. Both protein-energetic malnutrition and anorexia nervosa are nutritional 
and metabolic disorders connected with essential fatty acid deficiency30. In the both groups, 
we observed lower content of n-6 polyunsaturated fatty acids caused by lower content of 
linoleic acid (Study VI, VII). The decrease observed for protein-energetic malnutrition in all 
lipid classes could be inscribed to enhanced lipid peroxidation and to the raised utilisation of 
cholesterol from lipoprotein particles in peripheral tissues. The protein-energetic group had 
also reduced molar percentage of n-3 polyunsaturated fatty acids (α-linolenic and 
docosahexaenoic). Since we did not observe enhanced catabolism of lipoprotein particles in 
anorexia nervosa, but rather retardation of the catabolism, the lowered content of linoleic acid 
in anorectic patients is caused by the deficiency of essential fatty acids rather than by 
sustained oxidative stress. 
The obese group investigated had also lower content of n-6 polyunsaturated fatty acids 
(linoleic acid); whereas the concentration of triacylglycerols and total cholesterol (therefore 
also cholesteryl esters) were higher in the obese (Study VIII), the absolute concentrations of 
n-6 polyunsaturated fatty acids are higher than those of anorectic and protein-energetic 
malnutrition groups. This lower content has obviously significance. The insulin resistance that 
usually accompanies the obesity diminishes the activity of lipoprotein lipase in adipose tissue 
(particularly in visceral adipose tissue that is derived from the brown fat). Consequently, the 
secretion of triacylglycerol-rich VLDL particles is enhanced, HDL and LDL are richer in 
triacylglycerols; therefore, they are better substrates for hepatic lipase. The lipase forms small 
dense particles from LDL and reduces the number of HDL particles36. Hepatic lipase 
hydrolyses the sn-1 position in phospholipids (where there are monounsaturated and saturated 
fatty acids). During mild dietary restriction, linoleic acid is β-oxidised similarly to other 
polyunsaturated fatty acids37 and no changes were observed in the contents of this fatty acid 
(Study VIII). In this study, we did not notice any change in the content of linoleic acid in 
plasma non-esterified fatty acids.  
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 The higher content of palmitoleic acid (16:1n-7) reflect higher level of lipogenesis, 
whereas high concentration of non-esterified fatty acids indicate sustained release of fatty acid 
from adipose tissue. In the anorexia nervosa group (Study VI), both these two parameters 
were increased. On the contrary, in the patients with protein-energetic malnutrition (Study 
VII), neither the content of palmitoleic acid, nor the concentration of plasma non-esterified 
fatty acids were not changed. The anorectic patients have different distribution of adipose 
tissue compared to controls and realimentation brings about proportionally higher increase in 
visceral adipose tissue (in contrast to subcutaneous adipose tissue), so in the long run, the 
visceral fat has higher weight than in control groups38. 
The concentration of non-esterified fatty acids are higher in the obese, the low-calorie 
diet reduces them to the control values (Study VIII). The content of palmitoleic acid in plasma 
lipid classes and triacylglycerols of adipose tissue was decreased after the diet, which could 
point at the lowered lipogenesis. Concomitantly, the content of oleic acid was raised in the 
adipose tissue. Oleic acid is synthesised from stearic acid by delta 9 desaturase, which is 
induced by high cholesterol levels. During the diet, the sterols can accumulate in the 
adipocyte (Study VIII), therefore the desaturase activity can be increased. However, we did 
not observe the change in oleic acid content in plasma non-esterified fatty acids, but this could 
result from relatively slower mobilisation of oleic acid from the human adipocyte39. 
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 6 CONCLUSION 
The methodological part of the dissertation focused on some aspects of the gas 
chromatography analyses of fatty acids and minor plasma sterols. The analysis of fatty acids 
were thoroughly worked on with the respect to the type of matrix analysed (lipoproteins of the 
plasma, phosphatidylcholines vs. phospholipids) and we determined the limits of the methods 
for the determination of some fatty acids and noncholesterol sterols. On the basis of the 
results obtained, the analytical processes were modified to meet the requirements of clinical 
studies. 
The pathophysiological mechanisms responsible for the changes of metabolism of 
fatty acids and cholesterol in malnutrition and obesity are different. In anorexia nervosa, 
increased absorption of cholesterol together with slow catabolism of lipoproteins rich in 
triacylglycerols plays a role. Protein-energetic malnutrition is characterised by the diminished 
plasma content of cholesterol and essential fatty acid caused by their enhanced utilisation in 
peripheral tissues. Another factor important for the homeostasis of cholesterol and fatty acids 
is adipose tissue. This factor is notable during the low-calorie diet. Furthermore, we proved 
that the changes of plasma cholesterol can indirectly influence the metabolism of cholesterol 
and fatty acids in brain tissue in the experimental model.  
16 
 7 SUMMARY 
At present time, there is growing interest in two classes of lipids – sterols and fatty 
acids, which posses many different roles in living organisms. The concentrations of 
cholesterol biosynthetic precursors (lathosterol, desmosterol) reflect level of cholesterol 
biosynthesis, whereas the plasma phytosterol (campesterol, β-sitosterol) concentrations can be 
used for estimation of fractional absorption of dietary cholesterol. These groups are 
sometimes called together as noncholesterol sterols. The dissertation thesis dealt with the 
significance of analysis of noncholesterol sterols and fatty acid profile in various 
pathophysiological states. 
The methodology part of the thesis covered some aspects of analysis of these 
compounds with capillary gas chromatography. We found that for the minor fatty acid 
analysis, both the type of the column and the software used play an important role. The gas 
chromatography step contributes by the least part to the total error of the procedure, whereas 
the effect of other steps (extraction, thin-layer chromatography and methylation process) is 
more pronounced. The comparison of fatty acid profiles in lipoprotein particles with low and 
very low density revealed differences, but these differences were highly interindividual. We 
also found that it is possible to replace the analysis of the fatty acid profile in plasma 
phosphatidylcholines with the less laborious analysis of the sum of phospholipids. 
The sterol analysis was optimized by preferring the acetylation of samples and split 
mode of injection. The one-run analysis for the quantitation of minor sterols together with 
cholesterol was proven to be not reliable, therefore it was decided to use the method of two 
internal standards and two chromatographic runs. Comparison of the contribution of 
individual steps of sterol analysis showed that quantitative analysis of lanosterol and 5α-
cholestanol is burdened with the error excluding these analytes from clinical evaluation. 
In the experimental part of the thesis, the administration of hypolipidemic drugs (three 
statins and one fibrate) to brain lipids of male Wistar rats was studied. The statins used caused 
lowered content of cholesterol and diphosphatidylglycerol, which was counterbalanced by 
higher concentration of sphingolipids in brain lipids. The profiles of fatty acids were not 
considerably changed. 
Clinical part of the thesis focused on the metabolism of fatty acids and cholesterol in 
anorexia nervosa, proteino-energetic malnutrition and reduction diet in the obese. The patients 
with anorexia nervosa had elevated concentrations of total cholesterol, triacylglycerols, HDL-
cholesterol, campesterol and β-sitosterol. We also observed lower content of n-6 
17 
 polyunsaturated fatty acids in all lipid classes. These changes seem to be the result of complex 
mechanisms including diminished catabolism of lipoprotein particles rich in triacylglycerols, 
unchanged level of biosynthesis of cholesterol and enhanced resorption of exogenous 
cholesterol. 
Patients with proteino-energetic malnutrition exhibited lowered concentration of total 
cholesterol in plasma as well as in lipoprotein classes; concentration of apoA-I was higher, 
too. The concentration of lathosterol, indicator of cholesterol biosynthesis was not changed. 
The analysis of fatty acid profile showed higher content of monounsaturated and lowered 
content of polyunsaturated fatty acids. These metabolic changes in proteino-energetic 
malnutrition are connected more or less with higher utilization of cholesterol from lipoprotein 
particles in peripheral tissues. 
Reduction diet set at the content of fat in the diet within the range of 20 and 45 energy 
% lowers body weight in order of percents, but it has no marked impact on cholesterol 
biosynthesis. The results suggest the diet-induced changes in fatty acid composition are 
controlled by the calorie deficit of the diet and the proportion of dietary fat plays a minor role. 
Ten-week low energy reduction diet induced changes in the metabolism of both cholesterol 
and phytosterols, which can be ascribed either to lowered dietary absorption or deteriorated 
turnover of phytosterols from the adipose tissue. 
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